Histrelin0 vendors competing

No vendor pricing available for this peptide yet.

Research details

Histrelin — research data

Regulatory statusFDA-approved (Supprelin LA)
NCAA D1Banned

Overview

About Histrelin

Mechanism of action

GnRH agonist implant; 12-month sustained release

Safety profile

Implant site reactions, hot flashes, mood changes · Approved for precocious puberty and prostate cancer; implant; well-tolerated

Related pages

More on Histrelin

Failed to fetch